RUNX1 and leukemia: A second group analyzed somatic mutations in 8 leukemia patients from four French FPD/AML families, identified loss of function mutations in the second RUNX1 allele in 6 patients, and concluded that mutation of the remaining wild type RUNX1 allele was the most common secondary event (Antony-Debré et al., 2016).